We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$731M
AUM Growth
-$365M
Cap. Flow
-$340M
Cap. Flow %
-46.53%
Top 10 Hldgs %
45.16%
Holding
128
New
24
Increased
37
Reduced
18
Closed
39

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$18.7M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$11.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.99M
4
VRNT
Verint Systems
VRNT
+$9.95M
5
STOK icon
Stoke Therapeutics
STOK
+$9.42M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$31.2M
2
NVO
Novo Nordisk
NVO
+$20.9M
3
VTRS icon
Viatris
VTRS
+$13.3M
4
NVS icon
Novartis
NVS
+$9.61M
5
PTCT icon
PTC Therapeutics
PTCT
+$8.3M

Sector Composition

Rank Sector Weight
1 Healthcare 70.2%
2 Technology 11.72%
3 Industrials 2.28%
4 Consumer Discretionary 1.91%
5 Communication Services 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
126
PUT
DELISTED
Celgene Corp
CELG
– –
-300,000
Closed -$28.3M
BHVN
127
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-88,015
Closed -$4.53M
2 3 4 5
6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sphera Funds Management held 128 positions worth $731M, down 33% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sphera Funds Management withdrew a net $340M in Q2 2019, closing 39 positions and reducing 18 holdings. Its most notable exit was Gilead Sciences, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 55% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in Regeneron Pharmaceuticals worth $9.39M.

  • Sphera Funds Management's largest Q2 2019 buy was Regeneron Pharmaceuticals: 30,000 shares worth $9.39M.
  • Sphera Funds Management added most to Johnson & Johnson in Q2 2019, an estimated $18.7M increase.
  • Sphera Funds Management's biggest Q2 2019 reduction was Viatris, cutting an estimated $13.3M.
  • Sphera Funds Management fully exited Gilead Sciences in Q2 2019, selling an estimated $31.2M.
  • Sphera Funds Management's ten largest holdings make up 45% of its $731M portfolio in Q2 2019.
  • Sphera Funds Management opened 24 new positions and closed 39 in Q2 2019.
  • Sphera Funds Management's portfolio value fell 33% quarter-over-quarter to $731M.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.